News

EvoEndo® Announces Ambulatory Payment Classification (APC) Reassignments for Flexible Transnasal Esophagogastroduodenoscopy (EGD)

DENVER, CO, EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), is pleased to share recent decisions announced by the Centers for...

EvoEndo Wins 2022 MedTech Innovator Execution Award, AdvaMed Accel Virginia Shimer Rybski Memorial Award

BOSTON, October 24, 2022–MedTech Innovator, the largest accelerator of medical devices in the world, and AdvaMed Accel, the leading advocacy association for emerging medtech firms, today announced...

EvoEndo Poised to Transform Clinical Endoscopy Practice with the EvoEndo® Single-Use Unsedated Transnasal Endoscopy (TNE) System

Completes $8.4M Series A Financing to Initiate Rollout of the EvoEndo® Model LE Single-Use Gastroscope  Gastroenterologists can now offer pediatric and adult patients a safer, faster, and more...

EvoEndo Announces US FDA 510(k) Clearance for Single-Use Unsedated Transnasal Endoscopy (TNE) System

EvoEndo’s Single-Use Endoscopy System or the “EvoEndo System” eliminates the need for general anesthesia or conscious sedation during routine upper endoscopic procedures The EvoEndo System is...

EvoEndo and Micro-Tech Endoscopy Announce Partnership for Single-Use Unsedated Endoscopy System

EvoEndo® and Micro-Tech Endoscopy have signed a distribution agreement for the EvoEndo® Single-Use Endoscopy System, which eliminates the need for general anesthesia during routine endoscopic...

EvoEndo Raises $10.1 Million to Make Unsedated Transnasal Endoscopy a Reality for Patients and Physicians

Transnasal Endoscopy (TNE) eliminates the need for general anesthesia during routine endoscopic procedures lowering undue risks, costs, and burdens on patients and facilities DENVER, CO, June 3,...